PCI-32765 (Ibrutinib) 200mg | 99.01% APEXBIO TECHNOLOGY LLC Bruton’s tyrosine kinase (BTK) inhibitor Angiogenesis|BTK More Information Supplier Page × PCI-32765 (Ibrutinib)
ABT-888 (Veliparib) 10mM (in 1mL DMSO) | 98.95% APEXBIO TECHNOLOGY LLC Potent PARP inhibitor Chromatin/Epigenetics|PARP More Information Supplier Page × ABT-888 (Veliparib)
ABT-888 (Veliparib) Evaluation Sample | 98.95% APEXBIO TECHNOLOGY LLC Potent PARP inhibitor Chromatin/Epigenetics|PARP More Information Supplier Page × ABT-888 (Veliparib)
ABT-888 (Veliparib) 5mg | 98.95% APEXBIO TECHNOLOGY LLC Potent PARP inhibitor Chromatin/Epigenetics|PARP More Information Supplier Page × ABT-888 (Veliparib)
ABT-888 (Veliparib) 10mg | 98.95% APEXBIO TECHNOLOGY LLC Potent PARP inhibitor Chromatin/Epigenetics|PARP More Information Supplier Page × ABT-888 (Veliparib)
PCI-32765 (Ibrutinib) 50mg | 99.01% APEXBIO TECHNOLOGY LLC Bruton’s tyrosine kinase (BTK) inhibitor Angiogenesis|BTK More Information Supplier Page × PCI-32765 (Ibrutinib)
PCI-32765 (Ibrutinib) 10mg | 99.01% APEXBIO TECHNOLOGY LLC Bruton’s tyrosine kinase (BTK) inhibitor Angiogenesis|BTK More Information Supplier Page × PCI-32765 (Ibrutinib)
PCI-32765 (Ibrutinib) 5mg | 99.01% APEXBIO TECHNOLOGY LLC Bruton’s tyrosine kinase (BTK) inhibitor Angiogenesis|BTK More Information Supplier Page × PCI-32765 (Ibrutinib)
PCI-32765 (Ibrutinib) Evaluation Sample | 99.01% APEXBIO TECHNOLOGY LLC Bruton’s tyrosine kinase (BTK) inhibitor Angiogenesis|BTK More Information Supplier Page × PCI-32765 (Ibrutinib)
PCI-32765 (Ibrutinib) 10mM (in 1mL DMSO) | 99.01% APEXBIO TECHNOLOGY LLC Bruton’s tyrosine kinase (BTK) inhibitor Angiogenesis|BTK More Information Supplier Page × PCI-32765 (Ibrutinib)